{
  "pmcid": "6282568",
  "sha256": "c92a11858c89fe79f6ac83973717ef9166598d724ae7a3cea0eee76f607ca4cb",
  "timestamp_utc": "2025-11-09T22:49:42.740603+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.294603481624758,
    "reading_ease": 30.187727272727273,
    "word_count": 188
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial of High-Flow Nasal Oxygen in High-Risk Cardiac Surgical Patients"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "In this single-centre trial, 100 adult patients undergoing elective cardiac surgery were randomised 1:1"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility included COPD, asthma, recent lower respiratory tract infection, BMI ≥35 kg/m², or heavy smoking."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised 1:1 to receive HFNO (n=51) or standard oxygen therapy (n=49)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluated whether high-flow nasal oxygen (HFNO) reduces hospital length of stay compared to standard oxygen therapy"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was hospital length of stay, measured from surgery to discharge."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated with allocation concealment via a centralised online system."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Blinding was applied to surgical and nursing teams responsible for discharge decisions."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "100 adult patients undergoing elective cardiac surgery were randomised 1:1"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "HFNO (n=51) or standard oxygen therapy (n=49)"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Geometric mean hospital stay was 29% lower in the HFNO group (95% CI 11–44%, p=0.004)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Funding source]"
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}